Human immunodeficiency virus type 1 (HIV-1) infection of most human cells is dependent on cyclophilin A (CypA); however, the opposite phenomenon, known as CypA-dependent inhibition, is also observed in the combination of some capsid (CA) mutations and cell lines. Here, we identified a CA N121K mutant whose infection of 293T, Jurkat, and HeLa cells was impaired by CypA. The N121K mutant could be a useful tool for analyzing the mechanisms underlying CypA-dependent restriction.
T he host cellular protein cyclophilin A (CypA) binds to the proline-rich loop in the N-terminal region of the human immunodeficiency virus type 1 (HIV-1) capsid (CA) protein (1, 2) . Inhibition of the CA-CypA interaction by using competitive chemicals such as cyclosporine (CsA), introduction of mutations into the CypA-binding loop within CA, or RNA interference (RNAi)-mediated knockdown of endogenous CypA in target cells leads to reduced HIV-1 infectivity (3, 4 ). An initial model assumed that the incorporation of CypA into the virions facilitates uncoating of the HIV-1 core. However, recent studies show that the CACypA interaction in target cells, rather than that of virus-incorporated CypA, is important for HIV-1 infection (5, 6) . CypA catalyzes the cis-trans isomerization of proline peptide bonds, leading to conformational changes in CA and, in turn, the core structure. Although the CA-CypA interaction has been well characterized in vitro, the precise role played by CypA during HIV-1 replication is still unclear (3, 4) . Recent reports indicate that the CA-CypA interaction is involved not only in uncoating but also in nuclear import and integration (7, 8) .
HIV-1 infection of most human cells is dependent on CypA; however, the opposite phenomenon, known as CypA-dependent inhibition, is observed for some CA mutant viruses. A previous study showed that the passage of wild-type (WT) HIV-1 in HeLa-CD4 cells (when CypA was inhibited by CsA) resulted in the generation of two CA escape mutants, A92E and G94D (9) . These mutations tolerate the inhibition of CA-CypA interaction, but their replication in HeLa and H9 cells (although not in other cell lines such as 293T and Jurkat cells) becomes dependent on CsA (6, 10) . Several CA mutants, such as R132K and T54A, showed similar CsA-dependent phenotypes in a target cell-contingent manner (11) (12) (13) . These results imply the bidirectional function of CypA during HIV-1 replication. To better understand the function of CypA during HIV-1 replication, the viral regions that modulate CypA dependence must be identified. To this end, we tried to isolate HIV-1 mutants that can replicate in Jurkat cells in the absence of CypA. The newly isolated CA mutant N121K was generated by serial passage of a CypA-nonbinding HIV-1 mutant (NL4-3.P90A.A92E) in Jurkat cells (14) . In this paper, we report that N121K infection is inhibited in a CypA-dependent manner not only in HeLa and H9 cells but also in 293T and Jurkat cells.
We attempted to isolate HIV-1 mutants that replicate in Jurkat cells in the absence of CypA; HIV-1 infection of Jurkat cells is CypA dependent. Jurkat cells were infected with either WT virus or a CypA-nonbinding mutant, NL4-3.P90A.A92E, in the presence or absence of 1 M cyclosporine (CsA) as follows: culture I, NL4-3 without CsA; culture II, NL4-3 plus 1 M CsA; culture III, NL4-3.P90A.A92E without CsA; and culture IV, NL4-3.P90A.A92E plus 1 M CsA. After repeated passage (47 times), we succeeded in obtaining replication-competent viruses under all culture conditions. Sequence analysis of the entire gag region identified a virus from culture II that harbored a mutation in MA (V34I). The CA N121K and CA R132K mutants arose from cultures III and IV, respectively. The mutation in MA overlapped with a mutation reported to increase viral fitness in T-cell cultures (15) . Therefore, we studied two CA mutant viruses in detail. Since the R132K substitution identified in the virus from culture IV had also been identified previously (11, 16) , we focused on the N121K mutant (which harbored a mutation in the loop between helix 6 and helix 7), which arose from culture III (Jurkat cells infected with NL4-3.P90A.A92E in the absence of CsA).
We constructed an N121K substitution virus on a WT (NL4-3 or NL4-3-luc) and the CypA-nonbinding mutant (NL4-3.P90A.A92E or NL4-3.P90A.A92E-luc) backbone. Viral replication was then examined in Jurkat and H9 cells, and infection efficiency was examined in Jurkat, 293T, and HeLa cells. Figure 1A Previous studies show that CypA-dependent inhibition of infection by some CA mutants is greater in nondividing cells (16, 17) . Therefore, to investigate whether the mechanism underlying the CypA-dependent inhibition of infection by N121K mutants is similar to that observed for other CA mutants such as A92E, we tested whether cell growth arrest of CypA-or nontarget short hairpin RNA (shRNA)-transduced HeLa cells further inhibited infection by N121K. CypA knockdown by shRNA restored the infection efficiency of the N121K mutant (Fig. 1H) , suggesting that N121K is inhibited by CypA in the cytoplasm of the target cells as previously observed for other CsA-dependent mutant viruses (5, 18) . Aphidicolin-induced growth arrest markedly increased the level of N121K inhibition in HeLa cells (as was observed in A92E mutants) (16, 17) .
The A105T mutation is suppressive in CsA-dependent CA mutants, such as A92E (12) . Therefore, we next asked whether the A105T mutation suppressed the inhibition of N121K infectivity in 293T and HeLa cells. The infectivity of a dual mutant (N121K.A105T) virus was approximately 10-fold higher than that of a single mutant N121K virus in both 293T and HeLa cells. The A105T mutation fully restored the infection efficiency of the N121K mutant virus in 293T cells (Fig. 2A) . In contrast, the A105T-mediated rescue of infection efficiency in HeLa cells was only moderate, and it was increased by the addition of CsA (Fig. 2B) . Interestingly, the infection efficiency of the single A105T mutant decreased in both HeLa cells and 293T cells in the presence of CsA. Yang and Aiken suggested two possible explanations for why the A105T mutation may compensate for the structural changes caused by CypA or block the potent inhibitory factor activated by CypAdependent manner (12) .
We next determined which N121K replication step(s) is regulated by cellular CypA by measuring the synthesis of new reverse transcription (RT) products, or the production of two-long-terminal-repeat (2-LTR) circular DNA products, by quantitative real-time PCR (19) in the presence or absence of 1 M CsA. Viral infectivity was also measured in parallel (Fig. 3A) . There was no clear difference between the early and late N121K RT products in the presence or absence of CsA (Fig. 3B and C) . However, the addition of CsA increased the amount of N121K 2-LTR circular DNA products (Fig. 3D) . These results indicate that the replication of N121K is impaired at the nuclear transport stage. Although it is thought that the inhibition of these viruses occurs at either the RT, nuclear import, or integration stages, the replication step impaired by CypA (with regard to the A92E and G94D mutant viruses) is still controversial (12, 16, 17, 20) . Our quantitative PCR data show that the inhibition of N121K replication occurs at the nuclear import stage, supporting previous data showing that the CA-CypA interaction is involved in a series of viral replication steps at the nuclear import stage (8, 17) .
Next, we conducted infection experiments by titrating the dose of CsA and examining the effects on the infectivity of WT, A92E, and N121K viruses. 293T or HeLa cells were incubated with 0.5 ng of virus p24 in the presence of increasing concentrations of CsA. Along with the increase of the CsA concentration, the infectivity of the WT virus gradually decreased to approximately one-fifth of that of the virus in the control infection without CsA in 293T cells (Fig. 4A) . The infectivity of the A92E virus was not affected by the CsA concentration in 293T cells. In contrast, the infectivity of the N121K virus gradually increased with increasing CsA concentration (up to 0.15 M CsA). The infection efficiencies of N121K and the WT virus were comparable at CsA concentrations above 1.25 M. In HeLa cells, the titration curve for the N121K virus was similar to that of the A92E virus; however, the infectivity of N121K was less than that of A92E at most CsA concentrations tested (Fig.  4B) . The dual mutant virus (N121K.A92E) also showed increased infectivity in line with the increasing CsA concentration, although the infectivity was about 10-fold less than that of N121K in 293T cells and that of A92E and N121K in HeLa cells. This suggests that CypA-dependent restriction of the N121K.A92E dual mutant is increased in both cell types. Although the underlying mechanisms are still unclear, these data suggest that the CypA-dependent restriction factor(s) is expressed at different levels in 293T and HeLa cells. If the sensitivity of N121K to this hypothetical factor is higher than that of A92E, this may account for the different infectivities of A92E in 293T and HeLa cells. N121K might be very sensitive to this factor, and the A92E.N121K mutant is even more sensitive because A92E is potently restricted by the as-yet-unknown factor. This hypothesis can explain the different levels of N121K toleration shown by the introduction of an additional A105T mutation shown in Fig. 2 . In this report, we infected 293T, Jurkat, and HeLa cells with a CA mutant virus, N121K, which has a CsA-dependent phenotype. Although a similar CsA-dependent mutant virus, such as A92E, was previously identified, the CsA dependence was observed only in high-CypA-expressing cells, such as HeLa and H9 (9, 11, 12, 21) . Two hypotheses have been proposed to explain CsA-dependent infection by CA mutants. The first is that high levels of cellular CypA alter the stability and uncoating of the mutant viral core; the second is that a potent, as-yet-unknown HIV-1-inhibitory factor(s) interrupts the proper timing of uncoating or disrupts nuclear import or integration (5, 12, 18, 20) . In the present study, N121K replication was disrupted after the RT step and the magnitude of this inhibition varied in a cell-type-dependent manner. Inhibition of N121K virus infection appears to be stronger in HeLa cells than in 293T cells, and this can be explained by the potent as-yet-unknown restrictive factor differentially expressed in 293T and HeLa cells. Further work is needed to validate this model. The N121K mutation is located in the loop between helices 6 and 7. Two different groups reported that human TRIM5␣ inhibits N-tropic murine leukemia virus (N-MLV) infection in human cells by recognizing a comparable region within the viral CA (in the loop between helix 6 and helix 7) (22, 23) . Considering the conformational homology between N-MLV and HIV-1, this region might be accessible to human TRIM5␣. We knocked down endogenous TRIM5␣ in HeLa cells but found no significant difference in the infectivities of the A92E and N121K mutants (data not shown). This suggests that TRIM5␣ does not play a role in the CypA-dependent restriction of A92E and N121K. Still, the possibility that potent, as-yet-unknown HIV-1-inhibitory factors, which associate with CypA, may be able to access this region cannot be ruled out (5) .
Although CypA supports HIV-1 infection, some CA mutants showed CypA-dependent impairment of infection. Our data indicate that CypA impairs N121K infection, even in 293T and Jurkat cells that do not express CypA at very high levels. One of the proposed mechanisms for CypA-dependent restriction was that the high CypA expression level and mutation in CA modulate the stability of viral core (21) . In our data, addition of CsA rescues the infection of N121K virus in 293T cells, but the infection efficiency of N121K does not exceed that of the WT virus infection even at the highest CsA concentration. It could be said that the infection of N121K might require CypA for its infection, and CypA facilitates the HIV-1 infection at different stage of replication. Indeed, CsA treatment reduced the infectivity of the WT virus in 293T cells, and restriction was observed at the early RT production step (data not shown). The stability of viral core alone cannot explain why both CypA-dependent infection and CypA-mediated inhibition are observed for the same virus. Therefore, we could assume that a potent HIV-1-inhibitory factor(s) is also involved in the CypA-dependent restriction and that each CA mutant has a different sensitivity for it. Thus, the N121K CA mutant could be a useful tool for analyzing the mechanism(s) underlying CypA-dependent restriction of HIV-1 infection. Understanding this mechanism may also help to determine the exact role played by CypA during HIV-1 replication.
